Cargando…

Integrated systems modeling of severe asthma: Exploration of IL‐33/ST2 antagonism

Asthma is a complex, heterogeneous disease with a high unmet medical need, despite therapies targeting a multitude of pathways. The ability to quantitatively integrate preclinical and clinical data on these pathways could aid in the development and testing of novel targets and therapeutics. In this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gadkar, Kapil, Feigelman, Justin, Sukumaran, Siddharth, Rodrigo, Manoj C., Staton, Tracy, Cai, Fang, Bauer, Rebecca N., Choy, David F., Stokes, Cynthia L., Scheerens, Heleen, Ramanujan, Saroja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469696/ https://www.ncbi.nlm.nih.gov/pubmed/35857704 http://dx.doi.org/10.1002/psp4.12842

Ejemplares similares

gQSPSim: A SimBiology‐Based GUI for Standardized QSP Model Development and Application
por: Hosseini, Iraj, et al.
Publicado: (2020)

gPKPDSim: a SimBiology(®)-based GUI application for PKPD modeling in drug development
por: Hosseini, Iraj, et al.
Publicado: (2018)

A mechanistic PK/PD model to enable dose selection of the potent anti‐tryptase antibody (MTPS9579A) in patients with moderate‐to‐severe asthma
por: Rymut, Sharon M., et al.
Publicado: (2023)

Evaluation of HDL-modulating interventions for cardiovascular risk reduction using a systems pharmacology approach
por: Gadkar, Kapil, et al.
Publicado: (2016)

Mitigating the risk of cytokine release syndrome in a Phase I trial of CD20/CD3 bispecific antibody mosunetuzumab in NHL: impact of translational system modeling
por: Hosseini, Iraj, et al.
Publicado: (2020)

A Mechanistic Systems Pharmacology Model for Prediction of LDL Cholesterol Lowering by PCSK9 Antagonism in Human Dyslipidemic Populations
por: Gadkar, K, et al.
Publicado: (2014)

Clinical responses to ERK inhibition in BRAF(V600E)-mutant colorectal cancer predicted using a computational model
por: Kirouac, Daniel C., et al.
Publicado: (2017)

Erratum: Clinical responses to ERK inhibition in BRAF(V600E)-mutant colorectal cancer predicted using a computational model
por: Kirouac, Daniel C., et al.
Publicado: (2017)

Quantitative systems pharmacology model‐based investigation of adverse gastrointestinal events associated with prolonged treatment with PI3‐kinase inhibitors
por: Gadkar, Kapil, et al.
Publicado: (2021)

IL-33/ST2 immune responses to respiratory bacteria in pediatric asthma
por: Hentschke, Isabell, et al.
Publicado: (2017)

IL-33/ST2 antagonizes STING signal transduction via autophagy in response to acetaminophen-mediated toxicological immunity
por: Wang, Zengbin, et al.
Publicado: (2023)

Systems‐based digital twins to help characterize clinical dose–response and propose predictive biomarkers in a Phase I study of bispecific antibody, mosunetuzumab, in NHL
por: Susilo, Monica E., et al.
Publicado: (2023)

Seasonal variability of lung function and Asthma Quality of Life Questionnaire Scores in adults with uncontrolled asthma
por: Bauer, Rebecca N, et al.
Publicado: (2019)

Correction: Corrigendum: IL-33/ST2 immune responses to respiratory bacteria in pediatric asthma
por: Hentschke, Isabella, et al.
Publicado: (2017)

Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid Arthritis
por: Hong, Yeon-Sik, et al.
Publicado: (2011)

The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox
por: Allegra, Alessandro, et al.
Publicado: (2019)

ST2 and IL-33 in Pregnancy and Pre-Eclampsia
por: Granne, Ingrid, et al.
Publicado: (2011)

Role of the IL-33-ST2 axis in sepsis
por: Xu, Hui, et al.
Publicado: (2017)

IL-33/ST2 Axis in Organ Fibrosis
por: Kotsiou, Ourania S., et al.
Publicado: (2018)

The Role of IL-33/ST2 Pathway in Tumorigenesis
por: Larsen, Kristen M., et al.
Publicado: (2018)

The IL-33/ST2 Pathway in Cerebral Malaria
por: Glineur, Corine, et al.
Publicado: (2022)

IL‐33/ST2 pathway as upper‐hand of inflammation in allergic asthma contributes as predictive biomarker in heart failure
por: Mehrabi Nasab, Entezar, et al.
Publicado: (2022)

The Role of IL-33 in the Inflammation Process of Asthma and Atherosclerosis
por: Fulgheri, Gabriele, et al.
Publicado: (2011)

The IL-33/sST2 Axis in Thromboangiitis Obliterans
por: Sharebiani, Hiva, et al.
Publicado: (2020)

Upregulation of the IL-33/ST2 pathway in dry eye
por: Wang, Shudan, et al.
Publicado: (2019)

Neutralization of IL-33 modifies the type 2 and type 3 inflammatory signature of viral induced asthma exacerbation
por: Warren, Kristi J., et al.
Publicado: (2021)

A Six‐Stage Workflow for Robust Application of Systems Pharmacology
por: Gadkar, K, et al.
Publicado: (2016)

Critical roles of interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) in pulmonary disorders
por: Xu, Jiao, et al.
Publicado: (2022)

Antagonism of cytokine-induced eosinophil accumulation in asthma
por: Walsh, Garry M.
Publicado: (2012)

IL-33/ST2 axis in innate and acquired immunity to tumors
por: Jovanovic, Ivan P., et al.
Publicado: (2012)

The Association of Serum IL-33 and sST2 with Breast Cancer
por: Yang, Zhi-Ping, et al.
Publicado: (2015)

Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
por: Cohen, E. Suzanne, et al.
Publicado: (2015)

Critical Roles of IL-33/ST2 Pathway in Neurological Disorders
por: Abd Rachman Isnadi, Mohammad Faruq, et al.
Publicado: (2018)

IL-33-ST2 Axis in Liver Disease: Progression and Challenge
por: Sun, Zijian, et al.
Publicado: (2017)

Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation
por: Takatori, Hiroaki, et al.
Publicado: (2018)

Emerging Roles of IL-33/ST2 Axis in Renal Diseases
por: Chen, Wei-Yu, et al.
Publicado: (2017)

The Functional Roles of IL-33/ST2 Axis in Ocular Diseases
por: Qian, Yujing, et al.
Publicado: (2020)

The association of serum IL-33/ST2 expression with hepatocellular carcinoma
por: Pan, Xiaolan, et al.
Publicado: (2023)

Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma
por: Farahani, Rahim, et al.
Publicado: (2014)

The H3.3K27M oncohistone antagonizes reprogramming in Drosophila
por: Ahmad, Kami, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0bu9m90g2r3v9u40kao5baiq3l